MME for Attorneys: How Morphine Milligram Equivalents Quantify Pain Severity

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 26, 2026 | 7 min read

Morphine Milligram Equivalents (MME) convert different opioid prescriptions to a single potency scale, giving PI attorneys an objective metric for pain severity. Understanding MME levels in pharmacy records helps attorneys present opioid data persuasively in demand packages and counter defense arguments about excessive prescribing.

Morphine Milligram Equivalents (MME) is the standardized metric that converts any opioid prescription to a common potency scale, and it is the single most useful number PI attorneys can extract from pharmacy records to quantify pain severity in demand packages. A patient on 45 MME/day has documented moderate pain requiring meaningful opioid therapy. A patient on 90+ MME/day has documented severe pain requiring aggressive intervention. The number itself — objective, standardized, and universally understood by medical professionals and adjusters — speaks directly to injury severity.

• MME converts different opioids to a common scale: hydrocodone 10mg = 10 MME, oxycodone 10mg = 15 MME, tramadol 50mg = 5 MME
• The CDC 2022 Clinical Practice Guideline references 50 MME/day as a caution threshold and 90 MME/day as requiring careful reassessment — but these are clinical guidance, not prescriptive limits
• A patient's peak daily MME documents the maximum pain severity they experienced during treatment
• LienScripts calculates MME for every opioid prescription and includes it in the MERIT (Medication Evaluation & Rationale for Injury Treatment) report for demand packages
• According to James Wong, PharmD, founder of LienScripts, "MME is the universal language of opioid pain severity — when you tell an adjuster your client peaked at 90 MME/day, they understand immediately that this was a serious injury"

How MME Works

Different opioid medications have different potencies per milligram. A direct comparison of raw doses is misleading — 10mg of oxycodone is not the same as 10mg of hydrocodone. MME standardizes the comparison using published conversion factors (CDC Opioid Prescribing Guideline, 2022):

To calculate daily MME, multiply the single-dose MME by the number of doses per day:

• Oxycodone 10mg every 6 hours (4x/day) = 15 MME x 4 = 60 MME/day
• Hydrocodone 10mg every 4 hours (6x/day) = 10 MME x 6 = 60 MME/day
• Tramadol 50mg every 6 hours (4x/day) = 5 MME x 4 = 20 MME/day

[!KEY] The daily MME calculation transforms raw prescription data into a single number that quantifies pain severity. An attorney who tells an adjuster "my client was on 90 MME/day for three months" has communicated more about injury severity in one sentence than a page of subjective pain descriptions could convey.

MME Thresholds and What They Mean

Below 50 MME/day: Moderate Pain

Patients in this range are on opioid therapy but at doses consistent with moderate pain management. Typical regimens:

• Hydrocodone 5-10mg every 6-8 hours
• Tramadol 50-100mg every 6 hours
• Low-dose oxycodone (5mg every 8 hours)

This range documents legitimate pain requiring opioid intervention but does not typically trigger defense scrutiny about excessive prescribing.

50-89 MME/day: Significant Pain

This range represents clinically significant pain that has exceeded what moderate opioid doses can control. The CDC guideline notes that benefits of opioid therapy should be weighed against risks at this level. Typical regimens:

• Oxycodone 10mg every 6 hours (60 MME/day)
• Hydrocodone 10mg every 4-6 hours (40-60 MME/day)
• Extended-release oxycodone 20mg twice daily + immediate-release for breakthrough

[!TIP] When a patient's daily MME is between 50 and 89, present it in the demand as evidence that the pain was "clinically significant" — exceeding the threshold at which CDC guidelines recommend careful consideration of the risk-benefit balance. The prescriber's decision to maintain therapy at this level reflects a clinical judgment that the pain benefit outweighed the risk.

90+ MME/day: Severe Pain

Patients at 90+ MME/day have documented severe pain requiring aggressive opioid management. The CDC guideline recommends careful reassessment at this level — which means the prescriber has already reassessed and determined that the high dose remains medically necessary.

Typical regimens:

• Extended-release oxycodone 40mg twice daily + breakthrough doses
• Fentanyl patch 25-50mcg/hr + breakthrough opioid
• Multiple opioid agents for different pain components

A patient maintained at 90+ MME/day has the strongest possible pharmacy-based evidence of severe pain. The prescriber is managing a patient at the highest risk tier by choice because the pain demands it.

Using MME in the Demand Package

Peak MME Documents Maximum Severity

The highest daily MME the patient reached during treatment documents the peak pain severity. Present this number with context:

"The plaintiff's pharmacy records document a peak daily opioid dose of 90 MME/day — a level that the CDC Clinical Practice Guideline identifies as requiring careful reassessment, reflecting the treating physician's determination that the plaintiff's pain was severe enough to warrant aggressive opioid management at the highest CDC-recognized threshold."

MME Trajectory Documents Recovery Course

The MME trajectory over time documents the pain curve:

• Rapid increase to peak: The injury produced severe pain quickly (acute trauma)
• Sustained peak: Pain remained severe for an extended period (delayed healing, complications)
• Gradual taper: Pain slowly improved (long recovery)
• Rapid taper: Pain resolved after surgical intervention (surgery success supports surgical necessity)

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "The MERIT report includes an MME timeline that shows the opioid dose trajectory from first fill to last. Adjusters can see the entire pain curve in a single chart — peak severity, duration at peak, and taper rate."

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages.

MME Comparison Across Cases

MME also helps attorneys contextualize their case against benchmarks:

• Average PI patient: 20-40 MME/day for acute injuries
• Complex orthopedic cases: 50-80 MME/day post-surgically
• Severe/multi-site injuries: 80-120+ MME/day

Countering Defense Arguments About MME

"The prescriber exceeded CDC guidelines"

The CDC 2022 guideline explicitly states that MME thresholds are not prescriptive limits. The guideline says to "avoid increasing dosage above levels likely to yield diminishing returns in benefits relative to risks" and recommends "particular caution" above 90 MME/day — but it does not prohibit these doses when clinically indicated. A prescriber who maintains a patient at 90+ MME/day has made an individualized clinical determination that the pain warrants this dose, and the CDC guideline supports individualized assessment.

"The patient should have been on lower doses"

Counter by presenting the non-opioid medications prescribed concurrently. If the pharmacy record shows the patient was also on gabapentin, duloxetine, celecoxib, and a muscle relaxant — and still required 90 MME/day of opioid therapy — the multi-modal approach documents that the prescriber optimized non-opioid treatment first and the remaining pain still required high-dose opioids.

"High MME indicates addiction"

MME measures dose, not addiction. A patient who takes prescribed medications as directed at high doses has physical dependence (a normal pharmacological response), not addiction (a behavioral disorder). The distinction is well-established in clinical literature and in the DSM-5 diagnostic criteria for opioid use disorder, which explicitly exclude patients taking opioids as prescribed for pain.

[!KEY] An attorney who can fluently discuss MME — calculate it from the pharmacy record, present the peak and trajectory, and counter defense threshold arguments — has a significant advantage in settlement negotiations. MME is the objective language of opioid pain severity, and speaking it confidently signals to the adjuster that the demand is clinically grounded.

How LienScripts Tracks MME

LienScripts automatically calculates daily MME for every opioid prescription in the case record. The MERIT report includes:

• Daily MME at each opioid fill
• Peak daily MME with date
• MME trajectory over the treatment course
• Concurrent non-opioid medications at each MME level
• Context notes explaining clinical rationale

If your client has been on opioid therapy following a personal injury, LienScripts provides comprehensive MME documentation in the MERIT report — giving you the data to quantify pain severity objectively in the demand package.

Related Resources

• Morphine Milligram Equivalent (MME): What PI Attorneys Need to Know
• Opioid Tapering After Injury: Attorney Guide
• Opioid Prescribing Guidelines in PI Cases
• Non-Opioid Pain Treatments 2026: PI Attorney Guide
• Pharmacy Records for Demand Packages